1,2-distearoyllecithin has been researched along with Alzheimer Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antimisiaris, SG; Canovi, M; Clemente, C; Duyckaerts, C; Flores, O; Gobbi, M; Lazar, AN; Markoutsa, E; Masserini, M; Pampalakis, G; Re, F; Salmona, M; Sesana, S | 1 |
1 other study(ies) available for 1,2-distearoyllecithin and Alzheimer Disease
Article | Year |
---|---|
The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Antibodies, Monoclonal; Antibody Affinity; Biotin; Brain; Humans; Liposomes; Mice; Mice, Inbred BALB C; Particle Size; Peptide Fragments; Phosphatidylcholines; Phosphatidylethanolamines; Plaque, Amyloid; Polyethylene Glycols; Staining and Labeling; Static Electricity; Surface Plasmon Resonance; Ultracentrifugation | 2011 |